Delivery Order SPE2DB20D2002-SPE2DB22FL56T

Award Date 7/25/22
Potential Completion Date 7/26/22
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,959.18 firm-fixed-price delivery order is for the supply of 4567405225 units of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.61 delivery order contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product used for respiratory conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,252.01 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a November 2024 completion date and was not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,802.84 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a prescription medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.52 delivery order contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a period of performance through January 16, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,168.29 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Budesonide-Formoterol 160-4.5 10.2GM medication. This order is part of a larger $999,999,999 indefinite delivery contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,642.72 firm fixed price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for respiratory conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,182.32 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 80-4.5 10.2 gram medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,016.05 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,515.72, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB22FL56T
    Delivery Order

The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,703.08 firm-fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which enables AmerisourceBergen to efficiently provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is a subsidiary of Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:29 AM